Traumatic Brain Injury (TBI) is a major cause of death and disability worldwide. TBI can cause cognitive and memory function impairments which Current medical setting is not able to cure. In this s tudy, we hypothesized that mesenchymal s tem cells derived from Adipose tissue transplanted with RADA1-GGS IKVAV (GSIKVAV) can rescue cognitive function. An acute model of TBI was carried out in male Wis tar rats (n=36). Subjects were divided into 7 groups: Sham (receiving no treatment), PBS, GSIKVAV, Mesenchymal Stem Cells (MSCs), GSIKVAV+ MSCs. MSCs were s tained with BrdU. To evaluate the MSCs characterization flow cytometery was performed. IHC was done to s tudy the differentiation and viability. Behavioral tes ts including Open Field (OF), Elevated Plus Maze (EPM) and modified Neurological Severity Score (mNSS) were done to evaluate the sensory-motor function and anxiety. At day 30, animals were sacrificed. In order to detect inflammation toll like receptor3, 4, tumor necrosis factor α and glial fibrillary acidic protein were assessed using wes tern blot. CD markers (CD 105, 34) were reported to be positive for mos t of MSCs. The mNSS score significantly decreased among MSCs and MSCs + GSIKVAV groups. We observed a significant increase in the number of enteries to the open arm in the EPM tes t. The total dis tance was also increased in the OF tes t. These data sugges t that using MSCs with GSIKVAV can be a potential therapy for TBI patients according its neuroprotective and immunomodulatory effects.
